Page 2 - Flipbook
P. 2
Introduction
• This info booklet deals with advanced renal cell carcinoma (RCC)
• It includes information on an immune checkpoint inhibitor (ICI) combination
• This combination, pembrolizumab + axitinib, is an ICI + VEGF-targeted therapy
• This booklet is to provide you with information on the side effects to watch for, to help you to monitor and track
your symptoms between clinic visits and to help you inform your cancer care team about important information
The sections of the booklet are:
• Treatment
• Monitoring
• Communication
• Your Cancer Care Team will also provide you with separate detailed information sheets on your specific treatment
• There are other treatments for RCC that are not included in this booklet
VEGF: vascular endothelial growth factor
1
